Contract 36F79719D0134
Spark Therapeutics, Inc. · Department Of Veterans Affairs · March 10, 2025
Spark Therapeutics, Inc. was awarded a federal contract by Department Of Veterans Affairs on March 10, 2025 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 4 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on March 20, 2026. If all options are exercised, the contract could reach $25,000.
Contract details
- PIID
- 36F79719D0134
- Award type
- Fss
- Pricing
- Fixed Price With Economic Price Adjustment
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- March 10, 2025
- Latest action
- March 20, 2026
Description
APPROVED SUBCONTRACTING PLAN FOR 2026
Modification timeline
-
March 20, 2026Mod P00019 · Supplemental Agreement For Work Within Scope$0
-
February 5, 2026Mod P00018 · Supplemental Agreement For Work Within Scope6 MONTH SHORT TERM CONTRACT EXTENSION$0
-
November 21, 2025Mod P00017 · Supplemental Agreement For Work Within Scope2026 PUBLIC LAW PRICING UPDATE FOR 1 PRODUCT$0
-
November 7, 2025Mod P00016 · Supplemental Agreement For Work Within ScopeADMINISTRATIVE CHANGE TO UPDATE POC AND SIGNATORY AUTHORITY FORM$0
-
March 10, 2025Mod P00015$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36F79719D0134?
Contract 36F79719D0134 is a federal contract awarded to Spark Therapeutics, Inc. by Department Of Veterans Affairs on March 10, 2025 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 4 times since the base award.
Who won contract 36F79719D0134?
Spark Therapeutics, Inc. won contract 36F79719D0134 from Department Of Veterans Affairs.
How much is contract 36F79719D0134 worth?
Contract 36F79719D0134 has obligated $0 to date but carries a potential ceiling of $25,000 if fully funded and all options are exercised.